Supernus Pharmaceuticals controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries
2021
Supernus sues over Oxtellar XR patents
Lawsuit filed
Supernus Pharmaceuticals filed suit against Riconpharma and Ingenus, alleging patent infringement connected to their joint abbreviated new drug application for generic oxcarbazepine extended-release tablets. The infringement allegations are claims made by Supernus.
Source excerpt
Supernus Pharmaceuticals, Inc. (Supernus) has filed suit against Riconpharma LLC (Ricon) and Ingenus Pharmaceuticals LLC (Ingenus) over allegations of patent infringement.